Status:
COMPLETED
14-C ADME (Absorption, Disposition, Metabolism and Excretion) Study in Man
Lead Sponsor:
Abbott Products
Conditions:
Healthy Subjects
Eligibility:
MALE
18-55 years
Phase:
PHASE1
Brief Summary
This is an open-label study to determine the ADME (Absorption, Disposition, Metabolism and Excretion) of 14C labeled SLV337 after a single dose of an oral suspension.
Detailed Description
The Absorption, Disposition, Metabolism and Excretion of SLV337 will be investigated after a single dose of an oral suspension of 14C-SLV337.
Eligibility Criteria
Inclusion
- Inclusion Criteria
- BMI 18 - 28 kg/m2
- SBP 90-140
- DBP 50-90
- Exclusion Criteria
- Seizures,
- Orthostatic hypotension
Exclusion
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01176201
Start Date
July 1 2010
End Date
October 1 2010
Last Update
August 26 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Site Reference ID/Investigator# 61345
Zuidlaren, Netherlands, 9370 AE